Avita Medical received a buy rating reaffirmation from TD Cowen, alongside MarketBeat consensus ratings and SEC insider buying disclosures.
3 reports, 2 independent
Updated Oct 15
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Avita Medical received a buy rating reaffirmation from TD Cowen, alongside MarketBeat consensus ratings and SEC insider buying disclosures.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.MarketBeat is comparing Avita Medical's analyst ratings with those of Ambu A/S.1 source
TD Cowen reaffirmed a buy rating on Avita Medical, concurrent with insider buying disclosures.1 source
Keep exploring
The entities involved
-
Avita Medical
Australian public company
-
TD Cowen
American investment bank
-
MarketBeat
American personal finance blog
Related events
- Analyst rating updates for Krystal Biotech, including a buy rating from TD Cowen and a consensus rating from MarketBeat.
- Global Mofy AI Limited was listed on the stock exchange and received a consensus rating from MarketBeat.
- Alset Inc. filed reports with the Securities and Exchange Commission, and MarketBeat reported its average stock rating.
- MarketBeat reports on company ratings and targets for Nikon Corporation and Jabil, comparing business profiles and financial health.
- Spark I Acquisition Co. filed reports with the SEC and MarketBeat reported its average stock rating.